Dilated cardiomyopathy gene detection marker and application thereof
A technique for dilated cardiomyopathy and detection kit, applied in the field of molecular biology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Embodiment 1 A kind of dilated cardiomyopathy gene detection kit
[0045] Include the following components in the test kit of the present embodiment:
[0046] (1) Upstream primer SEQ ID NO.1; Downstream primer SEQ ID NO.2;
[0047] (2) DNA extraction reagents;
[0048] (3) Taq DNA Polymerase;
[0049] (4) PCR Buffer;
[0050] (5)Mg 2+ ;
[0051] (6) dNTPs;
[0052] (7) PCR stabilizers and enhancers.
Embodiment 2
[0053] Embodiment 2 A kind of dilated cardiomyopathy gene detection method
[0054] (1) Genomic DNA extraction
[0055] Whole-genome DNA was extracted from human heart tissue samples, and the concentration and purity of DNA were tested.
[0056] (2) Use the designed primer combination to amplify the SGCB gene
[0057] Use the designed primers (Table 1), configure them into the PCR amplification reaction system (Table 2), place them in the PCR reaction instrument, and use the amplification program (Table 3) to convert a DNA sequence containing the mutation site from amplified in the genome.
[0058] Table 1. Primer information
[0059] Primer name Primer sequence (5'-3') upstream primer SGCB-F SEQ ID NO.1 downstream primer SGCB-R SEQ ID NO.2
[0060] Table 2. PCR amplification reaction system
[0061] Reagent name Volume (μL) Reagent supplier PCR Mix(2×) 10 Nanjing Novizan Biotechnology Co., Ltd. SGCB-F(10um) 1 ...
Embodiment 3
[0067] Embodiment 3 Mutation site detection effect verification
[0068] The detection effect is verified by a certain number of irrelevant samples.
[0069] Based on the rarity of the onset of DCM, the sample included 500 patients without cardiomyopathy and 11 patients with DCM. It was verified by Sanger sequencing that no homozygous mutation (TT) at the c.243+6A>T site of SGCB was detected in 500 non-cardiomyopathy populations, only wild-type (AA) and heterozygous mutation (AT) existed, 11 cases All patients with dilated cardiomyopathy carry homozygous mutations at this site (TT).
[0070] The test results of 500 cases of non-cardiomyopathy population are as follows:
[0071]
[0072]
[0073]
[0074] For results in non-cardiomyopathy patients, see Figure 3-4 . in image 3 One case of AA homozygosity (sample 38), Figure 4 One case of AT heterozygosity (sample 276).
[0075] The above shows that the homozygous mutation of SGCB c.243+6A>T site can be used fo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com